Dr. Fred Beasley discusses how to improve experimental design and select the most appropriate animal models for your preclinical obesity research.

When conducting preclinical obesity research using animal models, researchers must consider many factors. They must select an appropriate model, define long-term dosing requirements and mitigate complications including subject-to-subject variability and regressions to and from an obese state arise.

In this webinar hosted by CrownBio, Dr. Fred Beasley presents tips and best practices for designing obesity studies, including how to choose the right animal model, best fit for study criteria and specific diet acceptance.

Presenters

Director of Scientific Engagement, Cardiovascular and Metabolic Disease
CrownBio

Production Partner

Crown Bioscience

Crown Bioscience brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, inflammation, cardiovascular, and metabolic disease. Our premier Translational Platforms help our clients accelerate their new drug development programs.

Additional Content From Crown Bioscience

Related Content

Cardio-Renal-Lymphatic Disease

Cardio-Renal-Lymphatic Disease

In this webinar, Dr. Giacomo Rossitto shares his research on heart failure and the related lymphatic dysfunction in patients.